ATNM short interest
Actinium Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 705,856 |
|---|---|
| Change vs prior report | -1,816 (-0.3%) |
| Change over six months | -44.3% |
| Days to cover | 8.68 (sector: 3.78) |
| Average daily volume | 81,289 |
| Rank in Healthcare | #170 of 922 by days to cover |
ATNM short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 705,856 | -0.3% | 8.68 | 81,289 |
| 2026-09-15 | 707,672 | +5.5% | 3.45 | 204,847 |
| 2026-08-31 | 670,644 | -12.7% | 4.57 | 146,666 |
| 2026-08-14 | 768,504 | -2.4% | 3.44 | 223,600 |
| 2026-07-31 | 786,981 | -4.0% | 10.35 | 76,001 |
| 2026-07-15 | 820,077 | -12.4% | 8.63 | 95,072 |
| 2026-06-30 | 936,708 | +1.0% | 6.72 | 139,494 |
| 2026-06-15 | 927,461 | -14.3% | 5.74 | 161,704 |
| 2026-05-29 | 1,082,196 | +3.4% | 11.16 | 96,959 |
| 2026-05-15 | 1,047,081 | -1.2% | 8.57 | 122,137 |
| 2026-04-30 | 1,059,722 | -3.1% | 2.99 | 354,435 |
| 2026-04-15 | 1,093,719 | -13.7% | 5.58 | 196,130 |
| 2026-03-31 | 1,267,895 | +20.8% | 8.72 | 145,439 |
| 2026-03-13 | 1,049,678 | -1.5% | 10.83 | 96,944 |
| 2026-02-27 | 1,066,143 | +0.5% | 8.24 | 129,326 |
| 2026-02-13 | 1,061,262 | +1.7% | 9.80 | 108,270 |
| 2026-01-30 | 1,043,950 | +8.3% | 8.30 | 125,729 |
| 2026-01-15 | 963,588 | +10.1% | 8.07 | 119,443 |
| 2025-12-31 | 875,498 | -1.7% | 4.93 | 177,565 |
| 2025-12-15 | 890,605 | +0.4% | 4.43 | 200,849 |
| 2025-11-28 | 887,393 | +3.9% | 3.15 | 281,306 |
| 2025-11-14 | 853,887 | +0.2% | 5.47 | 156,163 |
| 2025-10-31 | 851,981 | +3.8% | 2.47 | 344,787 |
| 2025-10-15 | 820,980 | -0.2% | 4.21 | 194,844 |
| 2025-09-30 | 822,396 | -6.1% | 7.96 | 103,308 |
import finzdata as yf
yf.Ticker("ATNM").short_interest # every report since 2017
yf.Client().short_interest(["ATNM"], start="2018-01-01")Healthcare short interest · ATNM price history · Who owns ATNM · All short interest